Ultrasound-Guided PRP and SVF Therapy Shows Sustained Improvement in Severe Knee Osteoarthritis: A 12-Month Retrospective Study

Abstract

Background: Knee osteoarthritis (OA) is a chronic disease caused by cartilage degeneration in the joint accompanied by joint deformities, pain, and stiffness. This study assessed the changes over time in the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) and Visual Analog Scale (VAS) values of patients after the combined application of stromal vascular fraction (SVF) and platelet-rich plasma (PRP). Material/Methods: A retrospective clinical study was designed. Thirty-four patients (8 males, 26 females, mean age 65.21 +/- 10.71, range 30-83 years) with pain due to knee osteoarthritis received SVF and PRP between 2019 and 2020. During and after the procedure, ultrasound-guided intra-articular spread was checked. Results: PRP+SVF injection provided significant improvement in the clinical symptoms of the patients measured according to their VAS and WOMAC scores, and this improvement continued until the twelfth month. The change in VAS scores of the patients was 1.76 +/- 1.18 (P=0.000) P =0.000) in the first month, 1.50 +/- 1.46 (P=0.000) P =0.000) in the sixth month, and 1.53 +/- 1.41 (P=0.000) P =0.000) in the twelfth month. VAS scores decreased 6.6 to 1.6 point at the end of the twelfth month. The WOMAC scores of the patients were 23.20 +/- 12.12 (P=0.000) P =0.000) in the first month, 19.48 +/- 12.0 (P=0.000) P =0.000) in the sixth month, and 20.01 +/- 10.48 (P=0.000) P =0.000) in the twelfth month. WOMAC scores decreased 51.99 to 20.48 point at the end of the twelfth month. Conclusions: Applying ultrasound-guided PRP+SVF injection into the knee joint once in OA patients improved VAS and WOMAC scores.